Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RISPERDAL
- Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
- Comparative Bioavailability of Risperidone.
- Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
- Reducing the Abuse Liability of Prescription Opioids
- Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
- "Extended" (Alternate Day) Antipsychotic Dosing
- Propranolol for Challenging Behaviors in Autism
- Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
- Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
- PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
- Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
- Nicotinic Receptors and Schizophrenia
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
- Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
- Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
- Bioavailability of LY03004 and Risperdal® Consta®
- Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
- Glutamate, Brain Connectivity and Duration of Untreated Psychosis
- The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia
- Bioequivalence Test for Risperdal 2mg of Janssen Korea
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
- Antipsychotic Effects on Brain Function in Schizophrenia
- An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
- Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis
- Omega-3 Dietary Supplements in Schizophrenia
- Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression
- Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
- Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition
- Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
- Clozapine for Cannabis Use in Schizophrenia
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition
- Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
- Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
- Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions
- A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
- An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia
- Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
- Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
- Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
- A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
- Effects of Ketamine and Risperidone on Cognition
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition
- An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder
- Bioequivalence Study of Risperidone 1 mg Tablets of Torrent Pharmaceuticals Limited, India and Risperdal® (Risperidone) 1 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fed Conditions
- Bioequivalence Study of Risperidone 1.0 mg Tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fasting Conditions
- Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
- Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
- Metabolic Effects of Antipsychotic Substitution in Children
- Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use
- Risperidone Maintenance Treatment in Schizophrenia
- Oral Uridine for Treatment of Bipolar Depression in Adolescents
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions
- Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions
- Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
- Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia
- A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia
- Treatment of Severe Childhood Aggression (The TOSCA Study)
- Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
- Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
- A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
- Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia
- Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose
- Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
- Quetiapine Extended Release Depression Symptoms
- The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)
- Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
- Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
- Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
- Pharmacogenomics in Autism Treatment
- First Episode Schizophrenia and Cannabis-Related Disorder Study
- Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
- High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
- Glucose and Lipid Metabolism on Antipsychotic Medication
- Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
- Metabolic Signatures and Biomarkers in Schizophrenia
- RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
- Antipsychotic Discontinuation in Alzheimer's Disease
- Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
- Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva
- Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder
- Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence
- Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
- Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study
- Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
- Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
- Risperdal Consta and Health Care Utilization in Patients With Schizophrenia
- Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
- A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
- Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
- A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
- A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children
- A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
- A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients
- An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
- A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
- A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
- Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
- Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-ac
- Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
- A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
- Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
- Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
- A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
- A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
- A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence
- A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
- Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
- Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia
- A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
- Metabolic Effects of Antipsychotics in Children
- Improving Work Outcome in People With Recent-onset Schizophrenia
- Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
- Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
- Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
- Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment
- Risperdal Consta for Bipolar Disorder
- Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
- A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
- A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes
- Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
- Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder
- A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
- A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
- Treating Behavioral Disturbances in Individuals With Dementia
- Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
- Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents
- Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
- Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
- Treatment and Outcome of Early Onset Bipolar Disorder
- Switching Medication to Treat Schizophrenia
- Treatment for First-Episode Schizophrenia
Clinical trials list
click for details